vimarsana.com

Page 24 - ஆரோக்கியம் பாதுகாப்பு இல் பால்டிமோர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Is Connecticut s plan to distribute COVID-19 vaccines fair?

Modern Healthcare Illustration / Getty Images With COVID vaccines expected to remain scarce into early spring, Connecticut has scrapped its complicated plans to prioritize immunizations for people under 65 with certain chronic conditions and front-line workers. Instead, the state will primarily base eligibility on age. Gov. Ned Lamont pointed to statistics showing the risk of death and hospitalization from COVID-19 rises significantly by age. Yet, shifting to an age-based priority system after health workers, nursing home patients and people 65 and up have been offered vaccines has frustrated people with health conditions such as cancer or diabetes who thought they would be next in line. It also could exacerbate the difficulty in getting people in underserved communities and those in minority racial and ethnic groups vaccinated, health experts said.

Pfizer and Moderna Are Studying Possible COVID Booster Shots—Why a Third Dose May Be Needed

Pfizer and Moderna Are Studying Possible COVID ‘Booster’ Shots Why a Third Dose May Be Needed Health.com 2/25/2021 © Provided by Health.com Adobe Stock The two COVID-19 vaccines currently in use in the US may be up to 95% effective in preventing infection after two doses, but the pharmaceutical companies behind them aren t stopping there. Pfizer and Moderna both announced this week that a third booster dose is being studied. A statement from Pfizer confirmed that studies involve participants in two age groups (18 to 55 and 65 to 85). Per NBC News, all were volunteers in Pfizer s initial phase 1-2 clinical trial, which began in May 2020. Each participant will be given the booster shot, which will be exactly the same as what they were given last year when they received two doses of the vaccine three weeks apart.

One dose of COVID-19 vaccine may be good for recovered patients

A pair of small studies found that patients previously infected with COVID-19 given their first vaccine dose showed the sort of robust immune response that people generally tend to have following their second dose.

Experts: Double-masking not a bad idea, though not supported by studies

How Dangerous Is Coronavirus to the Middle-Aged?

How Dangerous Is Coronavirus to the Middle-Aged? By Dennis Thompson HealthDay Reporter TUESDAY, Jan. 26, 2021 (HealthDay News) Middle-aged folks risk of dying from a COVID-19 infection is higher than they might think, a new study reports. The risk of death from COVID increases with age, but researchers have found that the upward curve grows exponentially steeper with every extra decade. One out of every 800 people entering early middle age at 45 will die from their COVID infection, 55-year-olds have a 1 in 240 risk of dying if they contract the coronavirus, and 65-year-olds have a 1 in 70 chance, said lead researcher Andrew Levin, a professor of economics at Dartmouth College in Hanover, N.H.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.